Suchergebnisse - "Poly(ADP-ribose) polymerase inhibitor"

PubPharm (6.306)

1

Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model

enthalten in: Anticancer research | 2024

von Morea, A. | Saravi, S. | Sisu, C. | +4

2

Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Zhou, Q. | Tu, X. | Hou, X. | +19

UpdateOf: Res Sq. 2023 Jun 09;:. - PMID 37333340

3

First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC : Applying clinical study findings to clinical practice in the United States

enthalten in: Cancer treatment reviews | 2024

von McKay, R. | Morgans, A. | Shore, N. | +3

4

New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma

enthalten in: Journal of cellular and molecular medicine | 2024

von Meneceur, S. | De Vos, C. | Petzsch, P. | +3

5

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer : A US Food and Drug Administration Pooled Analysis

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Fallah, J. | Xu, J. | Weinstock, C. | +10

6

Impact of Drp1-regulated changes in T cell activity on the combined antitumor effects of PARPi and PD-1 inhibitors

enthalten in: International immunopharmacology | 2024

von Ma, J. | Song, J. | Yi, X. | +5

7

NRDE2 deficiency impairs homologous recombination repair and sensitizes hepatocellular carcinoma to PARP inhibitors

enthalten in: Cell genomics | 2024

von Wang, Y. | Liu, X. | Zuo, X. | +24

8

Proteomic landscaping of high-grade serous ovarian carcinoma identifies stearoyl-CoA desaturase 5 as a potential predictive biomarker for poly(ADP-ribose) polymerase inhibitor response

enthalten in: Clinical and translational medicine | 2024

von Kim, S. | Kim, H. | Dan, K. | +8

9

A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Wang, F. | Yu, X. | Qian, J. | +9

10

Design, Synthesis, and Evaluation of [18F]BIBD-300 as a Positron Emission Tomography Tracer for Poly(ADP-Ribose) Polymerase-1

enthalten in: Molecular pharmaceutics | 2024

von Zheng, W. | Huang, Y. | Xie, Y. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[631]